Embolism

30 registered clinical trials studyying Embolism — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION NCT06134739	Hospital Universitario La Paz	—
Unknown	Prediction of the Risks of Cardiovascular Mortality NCT06103448	Jan Evangelista Purkyne University	—
Completed	SYMPHONY-PE Study for Treatment of Pulmonary Embolism NCT06062329	Imperative Care, Inc.	N/A
Active Not Recruiting	Aventus Thrombectomy System Pulmonary Embolism Clinical Study NCT05907564	Inquis Medical, Inc.	N/A
Unknown	Protect the Head to Head Study NCT05684146	Emboline	Phase 2
Recruiting	What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? NCT04436978	St. Antonius Hospital	Phase 4
Unknown	Embolism in COVID-19 Positive Patients NCT04910360	Afyonkarahisar Health Sciences University	—
Active Not Recruiting	Anticoagulation in Patients With Venous Thromboembolism and Cancer NCT04618913	Pfizer	—
Unknown	Evaluation of the Severity of Right to Left Shunt in PFO Patients After Systemic Embolism NCT04610463	University Hospital Hradec Kralove	N/A
Recruiting	Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism NCT04263038	Drahomir Aujesky	Phase 4
Unknown	Thrombembolism After Robot- Assisted Surgery in Urology NCT04796740	University Hospital Schleswig-Holstein	—
Completed	Blood Management During ECMO for Cardiac Support NCT03714048	St Vincent's Hospital, Sydney	—
Completed	Microembolic Detection in Acute Ischemic Stroke Patients With Atrial Fibrillation and Outcome NCT06018090	Centro Hospitalar De São João, E.P.E.	—
Completed	Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspec NCT04657120	Leiden University Medical Center	N/A
Unknown	Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism NCT03101384	European Georges Pompidou Hospital	—
Completed	Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevent NCT01925755	Bayer	—
Unknown	Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy NCT01823185	Imam Abdulrahman Bin Faisal University	Phase 4
Unknown	Oral Anticoagulation and Self-management NCT01878539	Osakidetza	N/A
Terminated	Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graf NCT01042444	Gardia Medical	N/A
Completed	Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization NCT01157338	Shiraz University of Medical Sciences	N/A
Completed	Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With NCT00781391	Daiichi Sankyo	Phase 3
Completed	The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice NCT00830570	Medco Health Solutions, Inc.	—
Completed	The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts NCT00453518	Lumen Biomedical	N/A
Completed	An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous NCT00403767	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Appr NCT00345618	Sanofi	Phase 3
Completed	Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients NCT00311753	Novartis Pharmaceuticals	Phase 3
Completed	Anticoagulant Therapy During Pacemaker Implantation NCT00479362	University of Turku	Phase 4
Completed	Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism NCT00509171	Unity Health Toronto	N/A
Completed	Aortic Arch Related Cerebral Hazard Trial (ARCH) NCT00235248	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Treatment for Blood Clots in the Veins of the Legs NCT00001713	National Institutes of Health Clinical Center (CC)	Phase 1